国家重点研发计划 (No. 2017YFA0505100),国家自然科学基金 (Nos. 31670834, 91839302),中国医学科学院蛋白组学与新药研发新技术创新单元 (No. 2019RU006) 资助。
Feng Xu
2 State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China;3 Research Unit of Proteomics & Research and Development of New Drug, Chinese Academy of Medical Sciences, Beijing 102206, ChinaPing Xu
1 School of Medicine, Guizhou University, Guiyang 550025, Guizhou, China;2 State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China;3 Research Unit of Proteomics & Research and Development of New Drug, Chinese Academy of Medical Sciences, Beijing 102206, ChinaNational Key Research and Development Project (No. 2017YFA0505100), National Natural Science Foundation of China (Nos. 31670834, 91839302), Research Unit of Proteomics & Research and Development of New Drug, Chinese Academy of Medical Sciences (No. 2019RU006).
赵丽萍,徐锋,张亚莉,徐平. 外泌体蛋白质组学在肝癌发生发展和治疗研究中的应用进展[J]. 生物工程学报, 2020, 36(10): 1992-2000
复制通信地址:中国科学院微生物研究所 邮编:100101
电话:010-64807509 E-mail:cjb@im.ac.cn
技术支持:北京勤云科技发展有限公司